Cases

Finkelstein Thompson is investigating potential claims on behalf of consumers who have purchased olive oil, including Kalamata brand 100% Pure Olive Oil and Botticelli brand 100% Pure Olive Oil, in connection with allegations that the product may be deceptively labeled.

A class action has been filed alleging that Volkswagen 2005-06 Jettas have defective door wiring harnesses, affecting the driver's side door, windows, locks, mirrors, fuel door and trunk release. If you had or currently have a Volkswagen 2005-06 Jetta and would like to discuss the investigation, please contact Finkelstein Thompson at 202.337.8000 email us at This email address is being protected from spam bots, you need Javascript enabled to view it

Finkelstein Thompson LLP ("FT") is investigating allegations that prior to September 2011, TheLadders.com, Inc., operating the job search website www.TheLadders.com deceptively advertised that in exchange for a monthly or yearly subscription fee for a premium account, job seekers would have access to all positions on its website which were "hand-selected," "pre-screened" and paid an annual salary of $100,000 or more. 

Recently the Attorney General of California initiated a lawsuit against Whole Foods, Trader Joes, Target Corp., and other food retailers, claiming that candied ginger and plum products sold by the retailers were not properly labeled to inform consumers of the lead content in the products. Lead has been identified by the State of California to be harmful to male and female reproductive systems. Finkelstein Thompson LLP is investigating what remedies are available to consumers that purchased the candied ginger and plum products from the retailers.

According to news reports, the deal-of-the-day website LivingSocial has suffered a massive security breach by unknown hackers that has potentially compromised 50 million LivingSocial accounts. Finkelstein Thompson LLP is investigating potential consumer remedies for those LivingSocial customers whose information may have been compromised.

Finkelstein Thompson is investigating recent complaints about Allianz Travel Insurance and Allianz Global Assistance Travel Insurance.  According to complaints, Allianz may be unfairly and unlawfully denying consumers travel insurance claims based on exclusions for pre-existing medical conditions without adequate disclosures of such restrictions.

Finkelstein Thompson is investigating allegations that Graco car seats equipped with a "QT Buckle" may be defective in that the QT Buckle may require "excessive force" in order to unlatch. The National Highway Traffic Safety Administration has been sifting through complaints regarding Graco car seats from 2009 through 2011. Numerous consumers have reported that they have had to struggle excessively to unlatch the buckle or, in some circumstances, that they have had to resort to cutting the seat belt in order to remove the child from the car seat. According to allegations made, the alleged defective buckles could prove to be seriously problematic in the event of an emergency that requires the rapid removal of a child from the car.

Shareholder law firm Finkelstein Thompson LLP is investigating potential claims on behalf of Tech Data Corporation (NASDAQ: TECD), whose share price declined after it disclosed its intent to restate some or all of its financial statements for 2011, 2012, and 2013.  If you are interested in discussing your rights as a Tech Data shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it

Apple MacBook Pro laptop computers are reportedly experiencing image persistence or "ghosting" problems on their retina display screens.  Finkelstein Thompson LLP is investigating potential consumer remedies for owners of Apple MacBook Pros experiencing the "ghosting" problems.

Finkelstein Thompson is investigating allegations that Ford F-150 trucks for the 2011 and 2012 model years may have a design defect which can cause the vehicles to shake, shudder, and potentially lose power in certain situations. According to reports online, the defect is potentially related to the Charge Air Cooler and may present a safety hazard. Additionally, sources indicate that while the manufacturer has issued a technical service bulletin to dealers acknowledging the manufacturing and/or design defect, it has not recalled the vehicles or offered to reimburse owners' costs incurred diagnosing and repairing the defect. Finkelstein Thompson is interested in speaking to consumers who have purchased a 2011 or 2012 Ford F-150 truck regarding the alleged defect. If you have purchased this product and wish to discuss this matter, please contact Finkelstein Thompson at 202-337-8000 or contact Finkelstein Thompson at This email address is being protected from spam bots, you need Javascript enabled to view it

Finkelstein Thompson is investigating whether Smart Balance, Inc.'s "Fat Free" milk product actually contains undisclosed fat. Smart Balance, Inc. began marketing "Fat Free" enhanced milks starting in 2008 that may contain 1 gram of fat per serving and 8 grams of fat per container. 1 gram of fat per serving is double the legal limit of 0.5 grams of fat per serving that a food is permitted to contain while carrying a "fat free" label.

WASHINGTON-(BUSINESS WIRE)-The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Asset Acceptance Capital Corp. (NASDAQ: AACC)("Asset Acceptance" or "the Company"), concerning the proposed acquisition of the Company by Encore Capital Group, Inc. Under the terms of the transaction, shareholders would receive $6.50 per share in cash. The total value of the transaction is approximately $200 million.

WASHINGTON-(BUSINESS WIRE)-The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Newport Bancorp, Inc. (NASDAQ: NFSB) ("Newport" or "the Company"), concerning the proposed acquisition of the Company by SI Financial Group, Inc. Under the terms of the transaction, shareholders would receive $17.55 per share in cash or 1.5129 shares of SI Financial Group common stock for every Newport share they own, subject to proration procedures so that 50 percent of the outstanding shares of Company common stock is converted into SI Financial common stock and the balance is converted into the cash consideration. The total value of the transaction is approximately $61.3 million.

WASHINGTON, DC – (BUSINESSWIRE) – The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of the drug manufacturer Impax Laboraties, Inc. (“IMPAX” or the “Company”) (NASDAQ: IPXL).  If you are interested in discussing your rights as an Impax shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .   

WASHINGTON-(BUSINESS WIRE)-The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Hot Topic, Inc.(NASDAQ: HOTT) ("Hot Topic" or "the Company"), concerning the proposed acquisition of the Company by Sycamore Partners . Under the terms of the transaction, shareholders would receive $14.00 per share in cash. The total value of the transaction is approximately $600M.

Finkelstein Thompson is investigating potential claims on behalf of consumers who have purchased Capatriti Brand 100% Pure Olive Oil, in connection with allegations that the product may be deceptively labeled.

Finkelstein Thompson LLP is pleased to announce that the Honorable Philip Gutierrez of the United States District Court, Central District of California, granted preliminary approval of a $7,750,000 million dollar settlement with Allergan, Inc. in the case titled, Dr. Julio Garcia v. Allergan, Inc., Case No. CV 11-9811-PSG (Ex). The settlement resolves a nationwide class action suit against Allergan based on allegations that the company promoted the use of one vial of BOTOX® Cosmetic on more than one patient. The lawsuit did not allege that BOTOX® Cosmetic is unsafe or ineffective. Allergan denies the allegations.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of First Financial Holdings, Inc.(NASDAQ: FFCH)("First Financial" or "the Company"), concerning the proposed acquisition of the Company by SCBT Financial Corp (NASDAQ: SCBT). Under the terms of the transaction, shareholders would receive 0.4237 shares of SCBT common stock for every share of First Financial they own, a current value of approximately $18.52 per share. The deal is valued at $302.4 million in the aggregate.

WASHINGTON—(BUSINESS WIRE)—The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Office Max Incorporated, (NASDAQ: OMX) (“Office Max” or “the Company”), concerning the proposed acquisition of the Company by Office Depot, Inc. (NASDAQ: ODP). Under the terms of the transaction, Office Max shareholders would receive 2.69 shares of Office Depot stock for every share of Office Max they own, a current value of approximately $11.24 per share. The total value of the transaction is about $1.2 billion.

WASHINGTON, DC- (BUSINESS WIRE)- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of BioClinica, Inc. (NASDAQ:BIOC) ("BioClinica" or "the Company") concerning the proposed acquisition of the Company by JLL Partners, Inc. . Under the terms of the transaction, BioClinica shareholders would receive $7.25 per share in cash in a tender offer worth approximately $124 million.

Plavix is a prescription drug for patients who have recently suffered a heart attack, stroke, or who have been diagnosed with Peripheral Artery Disease (poor circulation in the legs). Use of Plavix is indicated to keep blood platelets from sticking together and forming clots. Plavix can be used  in combination with aspirin to treat patients hospitalized with heart-related chest pain or heart attack.

WASHINGTON-(BUSINESS WIRE)-Shareholders of Epoch Holding Corporation. (NASDAQ: EPHC) ("Epoch" or "the Company"), may have potential claims concerning the proposed acquisition of the Company by TD Bank Group. Under the terms of the transaction, shareholders would receive $28.00 per share in cash, a 27.9% premium based on their pre-announcement closing price of $21.89. The total value of the transaction is approximately $668 million. At least one analyst has set a target price of $50.00 for the Company's shares.

If you took GranuFlo and Naturalyte and underwent hemodialysis and suffered any serious adverse health effects, please call (877) 800-1450 to speak to Finkelstein Thompson LLP attorneys who are available to analyze your situation at no cost or obligation to you. If you do not know if Granuflo was used for your hemodialysis treatment, Finkelstein Thompson LLP can even help you learn that information.

GranuFlo and Naturalyte are used to treat acute and chronic renal (kidney) failure during hemodialysis. The Food and Drug Administration ("FDA") recalled the drugs after they were linked to serious adverse health effects.  These drugs were part of a Class I recall which are the most serious type of recall issued by the FDA.  Class I recalls involve situations in which there is a reasonable probability that use of the recalled products will cause serious adverse health consequences or death. Indeed, as a result of the formulation of Naturalyte and GranuFlo, it is believed patients were at a higher risk of heart and cardiovascular injuries, including cardiac arrest, heart attacks, congestive heart failure, and death.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Titanium Metals Corp. (NASDAQ: TIE) ("Titanium" or "the Company"), concerning the proposed acquisition of the Company by Precision Castparts Corp. (NASDAQ: PCP). Under the terms of the transaction, Titanium shareholders would only receive $16.50 per share in cash, and at least one analyst has set a target price of $20.00 per share.  The total value of the transaction is approximately $2.9 billion.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of CreXus Investment Corp. (NASDAQ:CXS) ("CreXus"; or "the Company"), concerning the proposed acquisition of the Company by Annaly Capital Management Inc. Under the terms of the transaction, CreXus shareholders would receive $12.50 per share in cash. The total value of the transaction is approximately $839 million.

Finkelstein Thompson LLP is investigating allegations that Medtronic, Inc. illegally promoted and attempted to conceal the adverse events associated with InFUSE® Bone Graft ("InFUSE"), Medtronic, Inc.'s bio-engineered bone graft device used for spinal surgery. It is alleged that Medtronic, Inc. illegally promoted the off-label use of InFUSE for posterior lumbar surgery, when InFUSE is FDA-approved for anterior or abdominal lumbar surgery. It is also alleged that Medtronic, Inc. intentionally minimized or downplayed the risks of serious side effects related to the use of InFUSE, including ectopic or uncontrolled bone growth, inflammatory reactions, back and leg pain events, urinary retention, retrograde ejaculation, and implant displacement.

If you experienced complications from the use of InFUSE and wish to discuss your rights or provide information to assist the investigation, Finkelstein Thompson LLP welcomes your call. Finkelstein Thompson's Washington, D.C. office can be reached at (877)337-1050, or by email at This email address is being protected from spam bots, you need Javascript enabled to view it

Finkelstein Thompson LLP ("FT") is investigating patient claims as a result of receiving potentially contaminated steroid injections into the spinal area.  FT is also investigating claims of fungal infections from steroid injections into peripheral joint spaces, such as knees, shoulders, or ankles.

According to the CDC, healthcare facilities in twenty-three states were shipped lots of the contaminated steroids.  A list of those facilities can be found at the CDC's website.  The infected patients identified as of October 14, 2012, had all received the preservative-free (PF) methylprednisolone acetate (80mg/ml) injection from the three lots voluntarily recalled by the New England Compounding Center in Framingham, Massachusetts, on September 26, 2012.

If you believe you may have received one of the contaminated steroid injections and wish to discuss your rights or provide information to assist the investigation, Finkelstein Thompson LLP welcomes your call. Finkelstein Thompson's Washington, D.C. office can be reached at (877)337-1050, or by email at This email address is being protected from spam bots, you need Javascript enabled to view it

Finkelstein Thompson LLP (“FT”) is investigating patient claims as a result of receiving potentially contaminated steroid injections into the spinal area.  FT is also investigating claims of fungal infections from steroid injections into peripheral joint spaces, such as knees, shoulders, or ankles.

Finkelstein Thompson LLP ("FT") announces an investigation into Advantage Education LLC ("Advantage") and Duvera Billing Services LLC ("Duvera"). Advantage, which hosts the website www.online-home-careers.com, hosts an immediately available, private member only website offering an easy-to-follow checklist and Quick-start Manual on how to make money working from home ("Online Home Careers System") in exchange for a one-time payment of $97.95. The website also promises consumers a "powerful 365 day money back guarantee." According to consumer complaints, after they have purchased the Online Home Careers System, consumers receive a call offering continuing coaching services and access to an online library for an additional monthly fee. Consumers are then encouraged to execute an online Retail Installment Contract with Duvera for access to an online library of coaching and training material which are allegedly uninformative and worthless. According to consumer complaints, once consumers seek a refund, Advantage and Duvera either avoid all contact with consumers, or inform them that the money back guarantee only applies to the $97.95 one-time payment, and is inapplicable to the continuing monthly payments.

WASHINGTON-(BUSINESS WIRE)- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Physicians Formula Holdings, Inc. (NASDAQ GS:FACE) ("Physicians" or "the Company"), concerning the proposed acquisition of the Company by Markwins International Corporation. Under the terms of the transaction, Physicians' shareholders would receive $4.90 per share in cash. The total value of the transaction is approximately $74.9 million.

The FDA is warning consumers that certain over the counter products applied to the skin while used for the relief of mild muscle and joint pain are being reported as causing rare cases of serious skin injuries, including first to third degree burns, where the product is applied. Some of the burns had serious complications requiring hospitalization.

WASHINGTON--(BUSINESS WIRE)--The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Mediware Information Systems, Inc. ( the “Company”) (NASDAQ: MEDW), concerning the proposed acquisition of the Company by Thoma Bravo LLC. The current value of the per-share consideration is approximately $22.00, and the total value of the transaction is approximately $1.95 million.

Wayne Watson, 59, of Centennial, Colorado, has won a $7.3 million dollar settlement against the corporate owners of a popcorn plant in Jasper and two grocery chains. Watson won the verdict against Gilster-Mary Lee Corp. and The Kroger Co., a Cincinnati-based corporation that owns both Kroger and Dillons grocery stores, making him the first consumer diagnosed with "popcorn lung" a rare lung disease, to prevail in a lawsuit against a maker or purveyor of microwave popcorn.

Finkelstein Thompson LLP is investigating allegedly high levels of lead contained in Whole Food Market Inc.'s glucosamine chrondroitin complex supplements. According to a recent study, the Whole Foods supplements contain 13.2 micrograms of lead per daily serving, far exceeding the State of California's 0.5 microgram limit. Supplements sold in California exceeding 0.5 micrograms of lead must include a warning label to inform consumer of the high lead content, allegedly no such disclosures are contained on Whole Foods' glucosamine chondroitin complex supplements. At high levels, lead can adversely affect the nervous system and increase blood pressure.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of American Realty Capital Trust, Inc. (“American Realty” or the “Company”) (NASDAQ: ARCT), concerning the proposed acquisition of the Company by Realty Income Corp. (“Realty Income”) (NYSE: O). Under the terms of the transaction, American Realty shareholders would receive .2874 shares of Realty Income for each share of American Realty they own.  The current value of the per-share consideration is approximately $12.23, and the total value of the transaction is approximately $2.95 billion. 

Finkelstein Thompson LLP is investigating allegations that Medtronic, Inc. illegally promoted and attempted to conceal the adverse events associated with InFUSE® Bone Graft ("InFUSE"), Medtronic, Inc.'s bio-engineered bone graft device used for spinal surgery. It is alleged that Medtronic, Inc. illegally promoted the off-label use of InFUSE for posterior lumbar surgery, when InFUSE is FDA-approved for anterior or abdominal lumbar surgery. It is also alleged that Medtronic, Inc. intentionally minimized or downplayed the risks of serious side effects related to the use of InFUSE, including ectopic or uncontrolled bone growth, inflammatory reactions, back and leg pain events, urinary retention, retrograde ejaculation, and implant displacement.

WASHINGTON, DC- (BUSINESSWIRE)- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Sunrise Assisted Living, Inc. ("Sunrise" or the "Company")(NYSE: SRZ), concerning the proposed acquisition of the Company by Health Care REIT, Inc. Under the terms of the transaction, Sunrise shareholders would receive $14.50 for each share they own.

Recently the U.S. Consumer Product Safety Commission ("CPSC") announced a voluntary recall of the Flushmate III Pressure-Assisted Flushing System ("Flushmate III"). The Flushmate III presents a hazard of bursting at or near the vessel weld seam with a force strong enough to shatter the tank. The CPSC has already received 304 reports of the product bursting, resulting in property damage  and 14 impact or laceration injuries.

WASHINGTON, DC-(BUSINESSWIRE)- The law firm of Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Robbins & Meyers, Inc. ("Robbins" or the "Company") (NYSE: RBN), concerning the proposed acquisition of the Company by National Oilwell Varco, Inc. ("National") (NYSE: NOV). Under the terms of the proposed transaction, Robbins shareholders would receive $60.00 per share in cash, in a deal valued at approximately $2.5 billion.

Finkelstein Thompson is undergoing an investigation regarding a plan offered by Sprint for cell phones and smart phones. The plan is called the "Everything Messaging" Plan and it promises "unlimited nationwide, text, picture and video messaging to anyone on any network."

If you, a friend, or a family member has been affected by the "Everything Messaging" Plan offered by Sprint in any way, please contact Finkelstein Thompson at 202.337.8000 or email This email address is being protected from spam bots, you need Javascript enabled to view it

WASHINGTON, DC-(BUSINESSWIRE)- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of GenOn Energy, Inc. ("GenOn" or the "Company") (NYSE: GEN), concerning the proposed acquisition of the Company by NRG Energy, Inc. ("NRG") (NYSE: NRG). Under the terms of the transaction, GenOn shareholders would receive .1216 shares of NRG for every share they own. The current per-share value of the proposed consideration is approximately $2.28, and the total value of the transaction is approximately $1.7 billion.

WASHINGTON, DC-(BUSINESSWIRE- The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of GeoEye, Inc. ("GeoEye" or the "Company") (NASDAQ: GEOY), concerning the proposed acquisition of the Company by DigitalGlobe, Inc. ("DigitalGlobe") (NYSE: DGI). Under the terms of the transaction, GeoEye shareholders could elect to receive $20.27 in cash, 1.425 shares of DigitalGlobe, or 1.137 shares of DigitalGlobe and $4.10 in cash for each share of GeoEye they own. The current value of the average per-share consideration is approximately $21.77, and the total value of the transaction is approximately $900 million.

The law firm Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Lime Energy Co. ("Lime" or the "Company") (NASDAQ: LIME). If you are interested in discussing your rights as a Lime shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

Finkelstein Thompson LLP is investigating a recent recall by Stryker of their Rejuvenate and ABG II modular-neck-stem hip implant systems due to reported adverse side effects.  Stryker’s official website cites “fretting and/or corrosion at or about the modular-neck junction, which may result in adverse local tissue reactions manifesting with pain and/or swelling” as the reason for the recall. According to published reports, the recall was made after post-marking surveillance that may be predictive of a trend. 

CVS Caremark Corp. (CVS) is cutting 17 additional drugs from next year's docket on the basis that the drugs have "generic alternatives" that are cheaper and healthier than the brands on the chopping block.

Washington D.C. law firm Finkelstein Thompson LLP is investigating potential legal claims on behalf of those suffering side effects from the Biomet M2a Magnum Hip Implant. If you or a loved one has suffered such side effects, please contact call Finkelstein Thompson's Washington Office at (877) 337-1050 or email us at This email address is being protected from spam bots, you need Javascript enabled to view it

The law firm Finkelstein Thompson LLP is investigating legal claims on behalf of customers of entities related to Peregrine Financial Group, Inc. ("PFGBest" or "the Company"). If you are interested in discussing your rights or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it

The U.S. Department of Justice on July 2, 2012 was fined GlaxoSmithKline on three counts. GlaxoSmithKline plead guilty to two counts for failing to report safety data on Paxil and Wellburtin. $1 billion of the settlement will go towards settling the criminal wrong doing while the rest will cover the civil liabilities. This is the largest fraud settlement in U.S. history.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of St. Jude Medical, Inc. ("St. Jude"or the "Company"). According to a filed complaint, the Company, which manufactures pacemaker leads, concealed problems with several lines of its products. The complaint alleges that the company concealed electrical shorting problems with its Riata and Riata ST line of leads, and concealed protruding wire problems with its QuickSite and QuickFlex leads. The Riata and Riata ST lines were previously recalled in 2010, due to wire protrusion problems similar to those allegedly affecting the QuickSite and QuickFlex leads.  When news of the defects was revealed to the public, St. Jude's share price fell over 11% over a three day period, according to the complaint

Washington, D.C. shareholder law firm Finkelstein Thompson LLP is investigating potential legal claims on behalf of shareholders of ModusLink Global Solutions, Inc. ("ModusLink" or the "Company") (NASDAQ: MLNK). If you are interested in discussing your rights as a ModusLink shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

The Consumer Financial Protection Bureau (CFPB) has launched a public Consumer Complaint Database on credit cards, as well as a snapshot of the complaints received. Examples of these complaints include those on credit cards, as well as private student loans, bank products, and mortgages received through June 1 2012.

The FCC recently released a Public Notice seeking comment on the privacy and data security practices of mobile wireless service providers with respect to customer information stored on users' mobile phones. The FCC also sought to examine the existing privacy and security requirements related to that information.

Finkelstein Thompson LLP, Lovell Stewart Halebian Jacobson LLP and Zamansky & Associates, LLC announce the filing of an Amended Complaint on behalf of retail investors in the Facebook Initial Public Offering (IPO) against NASDAQ OMX Group, Inc. and The NASDAQ Stock Market LLC ("NASDAQ") to recover losses incurred in the botched May 18, 2012 IPO. The case seeks to compensate the ultimate retail stock investors, the "Moms and Pops" of America who wanted to participate in a little piece of the historic Facebook offering. The complaint alleges that NASDAQ negligently failed to properly execute and confirm investors' purchase and cancellation orders for Facebook stock, resulting in hundreds of millions of dollars in losses.

Finkelstein Thompson LLP is investigating allegations that the Hot Shot Bedbug & Flea Fogger is ineffective against bed bugs. The Hot Shot Bedbug & Flea Fogger is a do-it-yourself fogger that theoretically eliminates bedbugs by filling an entire room with aerosol insecticide.Often called "bug bombs," foggers have been sold for decades to combat common household insects.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of EasyLink Services Corp. ("EasyLink" or the "Company") (NASDAQ: ESIC), concerning the proposed acquisition of the Company by Open Text Corp. Under the terms of the transaction, EasyLink shareholders would receive $7.25 per share in cash, in a deal worth approximately $310 million.

J.P. Morgan Chase & Co. (NYSE: JPM) has suffered $2 billion or more in trading losses, according to breaking news reports.  A May 11, 2012 Wall Street Journal article indicates the “losses stemmed from wagers gone wrong in the bank's Chief Investment Office” and involved losses in derivative positions.  Following this revelation, J.P. Morgan shares fell dramatically in value.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Cost Plus, Inc. ("Cost Plus" or the "Company") (NASDAQ: CPWM) concerning the proposed acquisition of the Company by Bed Bath & Beyond, Inc. Under the terms of the transaction, Cost Plus shareholders would receive $22.00 per share in cash, in a deal worth approximately $495 million.

Finkelstein Thompson LLP is investigating allegations that Apple Inc. (NASDAQ: APPL) is double billing customers for music purchases made on iTunes.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of GTSI Corp.("GTSI" or "the Company") (Nasdaq:GTSI)

Finkelstein Thompson LLP investigates deceptive "green" product claims.

Finkelstein Thompson is investigating claims on behalf of individuals consuming the drug Pradaxa who may have experienced adverse bleeding events, i.e. hemorrhages.  Pradaxa is used to prevent strokes among patients with a dangerous irregular heartbeat, called atrial fibrillation, that tends to mainly impact the elderly. It is part of a new line of oral medicines called"direct thrombin inhibitors." The United States Food and Drug Administration first approved Pradaxa in October 2010.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Chesapeake Energy Corp. ("Chesapeake" or the "Company") (NYSE: CHK).  If you are interested in discussing your rights as a Chesapeake shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

Finkelstein Thompson LLP is investigating claims made by Jason Natural Brand, claiming their products are "All Natural" or "Pure Natural".

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Global Payments, Inc. ("Global" or the "Company") (NYSE: GPN). If you are interested in discussing your rights as a Global shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

Finkelstein Thompson LLP is investigating claims that users of eBay, Inc's "eBay Mobile" software application ("app") were improperly charged optional feature fees when using eBay Mobile to post items on eBay.

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of Swisher Hygiene, Inc. ("Swisher" or the "Company") (NASDAQ: SWSH).If you are interested in discussing your rights as a Swisher shareholder, or have information relating to this investigation, please contact Finkelstein Thompson's Washington, DC offices at (877) 337-1050 or by email at This email address is being protected from spam bots, you need Javascript enabled to view it .

Finkelstein Thompson LLP is investigating potential claims on behalf of shareholders of First Solar, Inc. ("First Solar" or the"Company") (NASDAQ: FSLR).

Finkelstein Thompson LLP is investigating allegations that LinkedIn, Inc. accesses contact lists from registered users' email programs without users' authorization. It is alleged that LinkedIn sends "Invitations to Connect" from the users' account to contacts in the user' email without informing the user. LinkedIn allegedly has the ability to access contacts even if the user has not specifically authorized this access. It is also alleged that LinkedIn App uses, uploads, stores and/or transfers the private address book data maintained on users' wireless mobile devices without first obtaining the device owner's consent.

Finkelstein Thompson LLP is investigating allegations that Google, Inc. intentionally used code to circumvent Apple Safari Internet web browser's default privacy settings to block third-party tracking on Apple computers, tablets and smartphones. It is alleged that Google, Inc. enabled tracking cookies to be installed on Safari users' Apple Mac, iPhone, ipod Touch and iPad without authorization or disclosure, although Google Inc.'s privacy policies state that "Safari is set by default to block all third-party cookies. If you have not changed those settings, this option effectively accomplishes the same thing as setting the [Google advertising cookie opt-out plugin]."

Finkelstein Thompson LLP ("FT") has launched an investigation of changes to the bylaws of Delaware corporations.

Finkelstein Thompson LLP is investigating potential claims on behalf of consumers who bought windows from Gorell Enterprises; Long Fence & Home; Serious Energy; THV Holdings; or Winchester Industries. The FTC recently investigated these companies for allegedly making unsubstantiated energy efficiency and money-saving claims about their windows, and Finkelstein Thompson is interested in speaking with consumers who purchased windows from these companies.

On February 15, 2012, the Federal Communications Commission ("FCC")announced new rules designed to strengthen protections against unwanted telemarketing calls to consumers. The FCC also intends the new rules to harmonize its policies with those of the Federal Trade Commission ("FTC"), making it easier for marketers to comply with all applicable regulations. But not all consumers are convinced that the new rules will actually cut down on unwanted telemarketing calls.

In recent years, many cases have been filed nationwide regarding health care providers' practices of charging fees for copying medical records for patients themselves, other health care providers, and other parties including attorneys. Such cases arise from the fact that the federal government and many states have implemented a patchwork of regulation regarding the level and types of permissible fees that can be charged.

Finkelstein Thompson LLP is investigating reports that AT&T (NYSE: T) is throttling data usage on its customers' smartphones covered by "unlimited" data plans. The throttling may restrict data speeds, which may result in slower web page loads and applications not functioning properly.

Finkelstein Thompson LLP is investigating TurboTax "refund processing service fees."  When a customer defers paying Intuit for its services up-front by electing to have applicable fees withheld from their tax refund, they are charged a Refund Processing Service Fee. In doing so, TurboTax does not disclose that the fee effects a very high interest rate for a short-period loan.

Finkelstein Thompson LLP investigates Dayton Model5NTX1 Refriferator/Freezer over alleged false Energy Star labeling.

Finkelstein Thompson LLP files suit agains the Kashi Company and Bear Naked, Inc.

Finkelstein Thompson LLP investigates fraudulent "All Natural" food claims

Finkelstein Thompson LLP investigates Naked Juice

This case has been preliminarily approved for settlement.  Please go to https://www.overdraftsettlement.com// for more information.

Finkelstein Thompson LLP Investigates Sutter Health Breach

Finkelstein Thompson LLP Investigates Tricare Data Breach.

Finkelstein Thompson LLP Investigates MF Global Holding Ltd.

Finkelstein Thompson LLP investigates Darvocet and Darvon Recall

Finkelstein Thompson LLP Announces An Investigation Involving Complications from Actos.

Finkelstein Thompson LLP Announces An Investigation Involving Complications from Transvaginal Mesh.

Finkelstein Thompson Announces Investigation of Bank of America Corp, Barclays Plc, Citigroup Inc, Credit Suisse Group AG, Deutsche Bank AG, HSBC Holdings Plc, JPMorgan Chase & Co, Lloyds Banking Group Plc and UBS AG

Finkelstein Thompson LLP Announces Investigation of Defective BMW Wheels

This case has been preliminarily approved for settlement.  Please go to http://www.barbri-classaction.com for more information.